Kolexia
Clere-Jehl Raphael
Médecine interne
Hopital Civil / Ihu
Strasbourg, France
91 Activités
29 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Choc COVID-19 Choc septique Maladie grave Sepsie Pneumopathie infectieuse Syndrome de détresse respiratoire de l'adulte Insuffisance respiratoire Coagulation intravasculaire disséminée

Industries

MSD
1 collaboration(s)
Dernière en 2022
Sanofi
1 collaboration(s)
Dernière en 2021
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Multicenter Retrospective Study of Invasive Fusariosis in Intensive Care Units, France.
Emerging infectious diseases   26 janvier 2024
Resilience and Mental-Health Symptoms in ICU Healthcare Professionals Facing Repeated COVID-19 Waves.
American journal of respiratory and critical care medicine   01 janvier 2024
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.
The New England journal of medicine   25 octobre 2023
Seneshock: Impact of Endothelial and Leukocyte Senescence in Circulatory Shock States
Essai Clinique (CHU Strasbourg)   18 août 2023
Staphylococcus epidermidis bloodstream infections are a cause of septic shock in intensive care unit patients.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases   28 juillet 2023
High-Dose Steroids for Nonresolving Acute Respiratory Distress Syndrome in Critically Ill COVID-19 Patients Treated With Dexamethasone: A Multicenter Cohort Study.
Critical care medicine   18 mai 2023
Changes in Body Temperature Patterns Are Predictive of Mortality in Septic Shock: An Observational Study.
Biology   22 avril 2023
REITAB-2: A Multicenter, Randomized, Double-Blind, Comparative, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Imipenem/Cilastatin/Relebactam in Adults With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia (EudraCT no. 2022-000081-18) (EUCTR no. 2022-501952-27-00) (IND no. 146614)
Essai Clinique (Evopoint Biosciences Inc.)   06 mars 2023
Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study.
Annals of intensive care   31 décembre 2022
Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).
Journal of clinical medicine   04 novembre 2022